Shanghai Kaibao Pharmaceutical CO.,Ltd (SHE:300039)
China flag China · Delayed Price · Currency is CNY
5.82
+0.09 (1.57%)
Apr 29, 2026, 3:04 PM CST

SHE:300039 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
786.25980.71593.31601.94694.691,345
Short-Term Investments
--924.87--58.32
Trading Asset Securities
305.0258.53180.02150.01136.0751.26
Cash & Short-Term Investments
1,0911,0391,698751.95830.761,455
Cash Growth
-44.58%-38.80%125.84%-9.49%-42.88%-0.23%
Accounts Receivable
424.78409.79471.99529.32530.33567.99
Other Receivables
1.320.3434.5110.3435.7746.77
Receivables
426.1410.13506.51539.67566.09614.76
Inventory
189.02200.41187.85171.79160.8165.14
Other Current Assets
350.44588.3122.8111.4716.7719.99
Total Current Assets
2,0572,2382,4151,4751,5742,254
Property, Plant & Equipment
273.26280.52267.85290.09304.66307.78
Long-Term Investments
1,3991,1661,6242,7301,312711.06
Goodwill
----9.0413.79
Other Intangible Assets
162.27163.57168.845.1144.2342.9
Long-Term Deferred Tax Assets
19.7921.4729.4431.6118.2615.1
Long-Term Deferred Charges
2.612.662.440.210.32-
Other Long-Term Assets
1,176906.4611.037.64996.4910.75
Total Assets
5,0904,7784,5184,5804,2593,356
Accounts Payable
127.5393.6199.37134.8591.0175.02
Accrued Expenses
0.591.2326.4623.2729.6915.92
Short-Term Debt
4.734.085.42---
Current Income Taxes Payable
23.6737.5731.6241.0835.543.47
Current Unearned Revenue
12.1112.4418.2945.6940.042.88
Other Current Liabilities
16.817.9951.1589.9699.6793.39
Total Current Liabilities
185.43166.91232.3334.85295.96190.68
Long-Term Unearned Revenue
46.5844.2648.0343.2639.5147.16
Long-Term Deferred Tax Liabilities
182.42148.47135.11168.71162.7773.06
Total Liabilities
414.43359.64415.45546.82498.24310.9
Common Stock
1,0461,0461,0461,0461,0461,046
Additional Paid-In Capital
8.628.628.628.628.628.62
Retained Earnings
2,6132,5482,3232,0501,7851,577
Comprehensive Income & Other
1,008815.43724.5926.33921.98413.53
Total Common Equity
4,6764,4184,1024,0313,7623,045
Minority Interest
0.270.390.971.64-0.72-0
Shareholders' Equity
4,6764,4194,1034,0333,7613,045
Total Liabilities & Equity
5,0904,7784,5184,5804,2593,356
Total Debt
4.734.085.42---
Net Cash (Debt)
1,0871,0351,693751.95830.761,455
Net Cash Growth
-44.65%-38.85%125.12%-9.49%-42.88%2.28%
Net Cash Per Share
1.040.991.620.720.791.39
Filing Date Shares Outstanding
1,0461,0461,0461,0461,0461,046
Total Common Shares Outstanding
1,0461,0461,0461,0461,0461,046
Working Capital
1,8712,0712,1831,1401,2782,064
Book Value Per Share
4.474.223.923.853.602.91
Tangible Book Value
4,5134,2553,9333,9863,7082,988
Tangible Book Value Per Share
4.314.073.763.813.552.86
Buildings
--386.31383.04372.25342.91
Machinery
--425.35441.06427.9407.9
Construction In Progress
--1.230.526.1834.15
Source: S&P Global Market Intelligence. Standard template. Financial Sources.